Pacific Biosciences of California, Inc. (PACB) Operating margin 2016–2025
Pacific Biosciences of California, Inc. (PACB) operating margin by fiscal year — reported operating income divided by reported revenue.
-346.2%FY2025 · since FY2016: -78.5% → -346.2%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -346.2% | -38.2 pp |
| FY2024 | -308.0% | -141.2 pp |
| FY2023 | -166.8% | +72.6 pp |
| FY2022 | -239.4% | -78.2 pp |
| FY2021 | -161.2% | -28.9 pp |
| FY2020 | -132.3% | -21.7 pp |
| FY2019 | -110.6% | +17.8 pp |
| FY2018 | -128.4% | -32.4 pp |
| FY2017 | -96.1% | -17.5 pp |
| FY2016 | -78.5% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice